however, it was difficult to prepare functionally active recombinant salmosin and to maintain a therapeutically effective concentration of the protein in the circulatory system by daily injections.
We have suggested that salmosin gene transfer mediated by cationic liposomes may be a practical alternative for cancer treatment.